2008 - Fellow of John Simon Guggenheim Memorial Foundation
2007 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
His scientific interests lie mostly in Internal medicine, Endocrinology, Cell biology, Pulmonary hypertension and Pulmonary artery. His research integrates issues of Membrane potential and Cardiology in his study of Internal medicine. The study incorporates disciplines such as Downregulation and upregulation, Transient receptor potential channel and Cell growth in addition to Endocrinology.
His studies in Cell biology integrate themes in fields like Programmed cell death, Vascular smooth muscle, Immunology and Cytosol. His research in Vascular smooth muscle intersects with topics in Muscle hypertrophy and Homeostasis. Jason X.-J. Yuan combines subjects such as Pathology, Vascular resistance, Lung, Vasoconstriction and Endothelium with his study of Pulmonary hypertension.
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Endocrinology, Pulmonary artery and Cell biology. His studies link Cardiology with Internal medicine. The Pulmonary hypertension study combines topics in areas such as Cancer research, Ventricular pressure, Pathology, Lung and Pharmacology.
His study looks at the relationship between Endocrinology and topics such as Membrane potential, which overlap with Depolarization. His Pulmonary artery study combines topics in areas such as Blood vessel, Circulatory system, Vascular disease, Smooth muscle and Vasodilation. Jason X.-J. Yuan has researched Cell biology in several fields, including Cell, Downregulation and upregulation and Vascular smooth muscle.
Jason X.-J. Yuan mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Endocrinology and Cell biology. In Internal medicine, he works on issues like Cell growth, which are connected to Cell. His Pulmonary hypertension research is multidisciplinary, relying on both Hypoxia, Lung, Pulmonary artery, Hemodynamics and Pharmacology.
His Hypoxia research is multidisciplinary, incorporating perspectives in Genetically modified mouse and Vascular resistance. His Endocrinology research integrates issues from Endothelial stem cell, Receptor, Transient receptor potential channel and Western blot. His Cell biology research includes elements of Oxidative stress, Downregulation and upregulation and Lung injury.
Pulmonary hypertension, Cell biology, Internal medicine, Downregulation and upregulation and Pulmonary artery are his primary areas of study. The concepts of his Pulmonary hypertension study are interwoven with issues in Hypoxia, Inflammation, Vascular resistance, Lung and Disease. His Cell biology study integrates concerns from other disciplines, such as Apoptosis and Gene.
His Internal medicine study incorporates themes from Endocrinology and Cardiology. His study focuses on the intersection of Downregulation and upregulation and fields such as Smooth muscle with connections in the field of Potassium channel, K channels, microRNA, Capsaicin and TRPV1. His Pulmonary artery research is multidisciplinary, incorporating elements of Ca2 signaling and Transient receptor potential channel.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages
Karl Ludwig Laugwitz;Alessandra Moretti;Jason Lam;Peter Gruber.
Cellular and molecular basis of pulmonary arterial hypertension.
Nicholas W. Morrell;Serge Adnot;Stephen L. Archer;Jocelyn Dupuis.
Journal of the American College of Cardiology (2009)
Inflammation, growth factors, and pulmonary vascular remodeling.
Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi.
Journal of the American College of Cardiology (2009)
Dysfunctional Voltage-Gated K+ Channels in Pulmonary Artery Smooth Muscle Cells of Patients With Primary Pulmonary Hypertension
Jason Xiao Jian Yuan;Ann M. Aldinger;Magdalena Juhaszova;Jian Wang.
Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension
Ying Yu;Ivana Fantozzi;Carmelle V. Remillard;Judd W. Landsberg.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Signaling molecules in nonfamilial pulmonary hypertension.
Lingling Du;Christopher C. Sullivan;Danny Chu;Augustine J. Cho.
The New England Journal of Medicine (2003)
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
Irene M. Lang;Raffaele Pesavento;Diana Bonderman;Jason X.-J. Yuan.
European Respiratory Journal (2013)
Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation
Vera A. Golovina;Oleksandr Platoshyn;Colleen L. Bailey;Jian Wang.
American Journal of Physiology-heart and Circulatory Physiology (2001)
Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.
Mehran Mandegar;Yuan Cheng B. Fung;Wei Huang;Carmelle V. Remillard.
Microvascular Research (2004)
PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression.
Ying Yu;Michele Sweeney;Shen Zhang;Oleksandr Platoshyn.
American Journal of Physiology-cell Physiology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: